A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brett Charlton, MD
Medical Director
Study Director - Moira Aitken, MDPrincipal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
100 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Insares
Mendoza, Mendoza Province, Argentina
- Hospital Interzonal General de Agudos Dr. Jose Penna
Bahía Blanca, Argentina
- Hospital Regional Español de Bahía Blanca
Buenos Aires, Argentina
- Hospital del Tórax Cetrángolo
Buenos Aires, Argentina
- Hospital San Roque
Córdoba, Argentina
- Mater Adult Hospital
Brisbane, Queensland, Australia
- Uz Vub
Brussels, Belgium
- Uz Leuven
Leuven, Belgium
- Chr Citadelle
Liège, Belgium
- Qeii Health Sciences Center
Halifax, Canada
- Institut de Recherches Cliniques de Montréal
Montreal, Canada
- the Ottawa Hospital, General Campus
Ottawa, Canada
- Fn Brno
Brno, Czechia
- Országos Korányi Tbc
Budapest, Hungary
- Klinikai Farmakológiai Központ
Debrecen, Hungary
- Mosdós Tüdőgyógyintézet
Mosdós, Hungary
- Törökbálint Tüdőgyógyintézet
Törökbálint, Hungary
- Pediatrics Pulmonary Department Rambam Healthcare Campus
Haifa, Israel
- Schneider Children'S Medical Center of Israel
Petah Tikva, Israel
- Spedali Civili Brescia
Brescia, Italy
- Irccs Ca' Granda Ospedale Maggiore Policlinico Mil
Milan, Italy
- Aou San Luigi Gonzaga
Orbassano, Italy
- Aziendao Spedaliera Universitaria
Parma, Italy
- Cystic Fibrosis Center Hospital San Carlo
Potenza, Italy
- Centro Fibrosi Cistica Policlinico Umberto I
Roma, Italy
- Azienda Ospedaliera Universitaria Integratadi Verona
Verona, Italy
- Instituto Jaliscience de Investigacion Clinica
Guadalajara, Mexico
- Unidad Médica de Occidente
Guadalajara, Mexico
- Arke Estudios Clinicos S.A
Mexico City, Mexico
- Ceprep- Hospital Universitario
Monterrey, Mexico
- Greenlane Hospital
Auckland, New Zealand
- Canterbury Respiratory Research Group
Christchurch, New Zealand
- Otago Respiratory Research Unit, Dunedin Hospital
Dunedin, New Zealand
- Szpital Dziecięcy Polanki Im. M. Płażyńskiego W Gdańsku Sp.
Gdansk, Poland
- Centrum Medyczne Karpacz Sa
Karpacz, Poland
- Wojewodzki Specjalistyczny Szpital Dzieciecy Im. W. Buszkowskiego
Kielce, Poland
- Wojewodzki Szpital Specjalistyczny Im.
Lodz, Poland
- Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu
Poznan, Poland
- Sanatorium Cassia-Villa Medica S.C.
Rabka-Zdrój, Poland
- Podkarpacki Osrodek Pulmonologii I Alergologii
Rzeszów, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 28 Feb 2017
- Completion
- 28 Feb 2017
- Last update posted
- 28 Oct 2020
- Registered enrollment
- 423
- Registry id
- NCT02134353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.